Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 19 studies | 48% ± 18% | |
| endothelial cell | 17 studies | 31% ± 15% | |
| fibroblast | 16 studies | 27% ± 10% | |
| pericyte | 13 studies | 26% ± 12% | |
| glutamatergic neuron | 12 studies | 48% ± 24% | |
| basal cell | 10 studies | 29% ± 13% | |
| endothelial cell of artery | 10 studies | 32% ± 17% | |
| neuron | 9 studies | 50% ± 22% | |
| epithelial cell | 9 studies | 37% ± 14% | |
| GABAergic neuron | 9 studies | 49% ± 23% | |
| connective tissue cell | 8 studies | 39% ± 15% | |
| smooth muscle cell | 8 studies | 21% ± 5% | |
| capillary endothelial cell | 8 studies | 28% ± 12% | |
| myofibroblast cell | 7 studies | 31% ± 5% | |
| mesothelial cell | 7 studies | 37% ± 17% | |
| oligodendrocyte precursor cell | 7 studies | 23% ± 6% | |
| interneuron | 6 studies | 52% ± 16% | |
| progenitor cell | 5 studies | 31% ± 16% | |
| cardiac muscle cell | 5 studies | 17% ± 1% | |
| ionocyte | 4 studies | 32% ± 13% | |
| pancreatic A cell | 4 studies | 77% ± 13% | |
| type B pancreatic cell | 4 studies | 63% ± 19% | |
| podocyte | 4 studies | 40% ± 2% | |
| granule cell | 4 studies | 41% ± 5% | |
| retinal ganglion cell | 4 studies | 43% ± 10% | |
| amacrine cell | 4 studies | 28% ± 8% | |
| pancreatic D cell | 3 studies | 74% ± 17% | |
| abnormal cell | 3 studies | 27% ± 7% | |
| GABAergic interneuron | 3 studies | 44% ± 3% | |
| microglial cell | 3 studies | 49% ± 11% | |
| extravillous trophoblast | 3 studies | 50% ± 11% | |
| placental villous trophoblast | 3 studies | 82% ± 4% | |
| club cell | 3 studies | 28% ± 3% | |
| retina horizontal cell | 3 studies | 31% ± 5% | |
| retinal bipolar neuron | 3 studies | 30% ± 4% | |
| retinal cone cell | 3 studies | 27% ± 6% | |
| retinal rod cell | 3 studies | 23% ± 3% | |
| Mueller cell | 3 studies | 22% ± 4% | |
| GABAergic amacrine cell | 3 studies | 32% ± 6% | |
| ON-bipolar cell | 3 studies | 26% ± 6% | |
| glycinergic amacrine cell | 3 studies | 23% ± 2% | |
| rod bipolar cell | 3 studies | 31% ± 5% | |
| endothelial cell of vascular tree | 3 studies | 23% ± 6% | |
| pancreatic ductal cell | 3 studies | 61% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 2362.29 | 244 / 245 | 100% | 86.19 | 501 / 502 |
| adrenal gland | 100% | 7194.68 | 258 / 258 | 99% | 87.22 | 228 / 230 |
| ovary | 100% | 4589.19 | 180 / 180 | 92% | 35.95 | 395 / 430 |
| pancreas | 98% | 1762.45 | 323 / 328 | 92% | 44.34 | 163 / 178 |
| kidney | 100% | 1990.06 | 89 / 89 | 85% | 36.97 | 767 / 901 |
| breast | 100% | 2444.31 | 459 / 459 | 85% | 35.38 | 950 / 1118 |
| lung | 99% | 2033.51 | 575 / 578 | 77% | 37.48 | 890 / 1155 |
| uterus | 100% | 2228.40 | 170 / 170 | 76% | 43.45 | 349 / 459 |
| bladder | 100% | 2561.14 | 21 / 21 | 74% | 47.57 | 375 / 504 |
| brain | 93% | 3059.58 | 2444 / 2642 | 77% | 22.44 | 540 / 705 |
| skin | 82% | 2439.85 | 1483 / 1809 | 79% | 44.45 | 371 / 472 |
| esophagus | 98% | 1167.69 | 1415 / 1445 | 54% | 22.31 | 98 / 183 |
| thymus | 57% | 418.50 | 371 / 653 | 89% | 51.54 | 539 / 605 |
| adipose | 100% | 2155.62 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| intestine | 85% | 1154.81 | 818 / 966 | 13% | 4.29 | 71 / 527 |
| heart | 95% | 1729.20 | 815 / 861 | 0% | 0 | 0 / 0 |
| stomach | 67% | 726.67 | 242 / 359 | 15% | 3.71 | 43 / 286 |
| tonsil | 0% | 0 | 0 / 0 | 80% | 35.78 | 36 / 45 |
| eye | 0% | 0 | 0 / 0 | 76% | 14.54 | 61 / 80 |
| spleen | 60% | 429.36 | 144 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 44% | 410.37 | 586 / 1335 | 0% | 0 | 0 / 0 |
| liver | 13% | 85.29 | 29 / 226 | 26% | 9.11 | 105 / 406 |
| muscle | 10% | 59.21 | 77 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 1.28 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0015693 | Biological process | magnesium ion transport |
| GO_0050890 | Biological process | cognition |
| GO_0018279 | Biological process | protein N-linked glycosylation via asparagine |
| GO_0006487 | Biological process | protein N-linked glycosylation |
| GO_1903830 | Biological process | magnesium ion transmembrane transport |
| GO_0055085 | Biological process | transmembrane transport |
| GO_0008250 | Cellular component | oligosaccharyltransferase complex |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0015095 | Molecular function | magnesium ion transmembrane transporter activity |
| Gene name | TUSC3 |
| Protein name | Tumor suppressor candidate 3 Tumor suppressor candidate 3 isoform b Tumor suppressor candidate 3 isoform a Tumor suppressor candidate 3 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TUSC3) (Oligosaccharyl transferase subunit TUSC3) (Magnesium uptake/transporter TUSC3) (Protein N33) |
| Synonyms | N33 |
| Description | FUNCTION: Acts as accessory component of the N-oligosaccharyl transferase (OST) complex which catalyzes the transfer of a high mannose oligosaccharide from a lipid-linked oligosaccharide donor to an asparagine residue within an Asn-X-Ser/Thr consensus motif in nascent polypeptide chains. Involved in N-glycosylation of STT3B-dependent substrates. Specifically required for the glycosylation of a subset of acceptor sites that are near cysteine residues; in this function seems to act redundantly with MAGT1. In its oxidized form proposed to form transient mixed disulfides with a glycoprotein substrate to facilitate access of STT3B to the unmodified acceptor site. Has also oxidoreductase-independent functions in the STT3B-containing OST complex possibly involving substrate recognition. .; FUNCTION: Magnesium transporter. . |
| Accessions | A0A0A0MTC2 D6RDV0 Q6QQE4 ENST00000382020.8 [Q13454-2] Q6Q320 ENST00000509380.5 ENST00000503731.6 [Q13454-1] Q6Q319 ENST00000510836.5 ENST00000506802.5 Q13454 D6RIY7 ENST00000515859.5 ENST00000511783.2 D6RA37 |